{"id":"NCT01547715","sponsor":"Novartis","briefTitle":"Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India","officialTitle":"A Phase 3, Multi-center, Open-label Study to Evaluate Immunogenicity and Safety of Novartis Meningococcal ACWY Conjugate Vaccine (MenACWY-CRM) in Healthy Subjects From 2 to 75 Years of Age in India.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-03","primaryCompletion":"2014-04","completion":"2014-04","firstPosted":"2012-03-08","resultsPosted":"2014-12-31","lastUpdate":"2018-10-09"},"enrollment":180,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Bacterial Meningitis"],"interventions":[{"type":"BIOLOGICAL","name":"Meningococcal ACWY conjugate vaccine","otherNames":[]}],"arms":[{"label":"MenACWY - 2 - 10 Years old","type":"EXPERIMENTAL"},{"label":"MenACWY - 11 - 18 Years old","type":"EXPERIMENTAL"},{"label":"MenACWY - 19 - 75 Years old","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the immunogenicity of a single injection of Novartis Meningococcal ACWY conjugate vaccine in healthy subjects from the age of 2 years and above in India.","primaryOutcome":{"measure":"Percentages of Subjects With Human Serum Bactericidal Assay (hSBA) Seroresponse Against N.Meningitidis Serogroup A.","timeFrame":"Day 29 (1 month post vaccination)","effectByArm":[{"arm":"2 - 10 Years","deltaMin":75,"sd":null},{"arm":"11 - 18 Years","deltaMin":76,"sd":null},{"arm":"19 - 75 Years","deltaMin":66,"sd":null},{"arm":"Overall (â‰¥2 Years)","deltaMin":72,"sd":null}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":4,"countries":["India"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":60},"commonTop":["INJECTION SITE PAIN","HEADACHE","CHILLS","UPPER RESPIRATORY TRACT INFECTION"]}}